FUTIBATINIB: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 May 2024

  • curprev 10:4510:45, 9 May 2024‎ Hafiza Amna Qadeer talk contribs‎ 1,225 bytes −12‎ No edit summary
  • curprev 10:3710:37, 9 May 2024‎ Hafiza Amna Qadeer talk contribs‎ 1,237 bytes +1,237‎ Created page with "{{DrugProjectFormSinglePage |authorTag=HAFIZA AMNA QADEER, MD |OTC=Yes |genericName=FUTIBATINIB |aOrAn=a |drugClass=Kinase Inhibitor |indicationType=treatment |indication=* of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements. |adverseReactions=1* Nail Toxicity, stomatitis, dry skin, dry eye, alopecia 2* Musculos..."
Retrieved from "https://www.wikidoc.org/index.php/FUTIBATINIB"